Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

B. Eliasson; D. Moller-Goede; K. Eeg-Olofsson; C. Wilson; J. Cederholm; P. Fleck; M. Diamant; M.R. Taskinen; U. Smith

doi:10.1007/s00125-011-2447-3

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

B. Eliasson, D. Moller-Goede, K. Eeg-Olofsson, C. Wilson, J. Cederholm, P. Fleck, M. Diamant, M.R. Taskinen, U. Smith

Internal medicine

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	915-925
Journal	Diabetologia
Volume	55
Issue number	4
DOIs	https://doi.org/10.1007/s00125-011-2447-3
Publication status	Published - 2012

Access to Document

10.1007/s00125-011-2447-3

Cite this

Eliasson, B., Moller-Goede, D., Eeg-Olofsson, K., Wilson, C., Cederholm, J., Fleck, P., Diamant, M., Taskinen, M. R., & Smith, U. (2012). Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. Diabetologia, 55(4), 915-925. https://doi.org/10.1007/s00125-011-2447-3

@article{7188efc9253d4784ac8c3eb77ec8e671,

title = "Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study",

author = "B. Eliasson and D. Moller-Goede and K. Eeg-Olofsson and C. Wilson and J. Cederholm and P. Fleck and M. Diamant and M.R. Taskinen and U. Smith",

year = "2012",

doi = "10.1007/s00125-011-2447-3",

language = "Undefined/Unknown",

volume = "55",

pages = "915--925",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Verlag",

number = "4",

}

Eliasson, B, Moller-Goede, D, Eeg-Olofsson, K, Wilson, C, Cederholm, J, Fleck, P, Diamant, M, Taskinen, MR & Smith, U 2012, 'Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study', Diabetologia, vol. 55, no. 4, pp. 915-925. https://doi.org/10.1007/s00125-011-2447-3

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. / Eliasson, B.; Moller-Goede, D.; Eeg-Olofsson, K.; Wilson, C.; Cederholm, J.; Fleck, P.; Diamant, M.; Taskinen, M.R.; Smith, U.

In: Diabetologia, Vol. 55, No. 4, 2012, p. 915-925.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

AU - Eliasson, B.

AU - Moller-Goede, D.

AU - Eeg-Olofsson, K.

AU - Wilson, C.

AU - Cederholm, J.

AU - Fleck, P.

AU - Diamant, M.

AU - Taskinen, M.R.

AU - Smith, U.

PY - 2012

Y1 - 2012

U2 - 10.1007/s00125-011-2447-3

DO - 10.1007/s00125-011-2447-3

M3 - Article

C2 - 22237690

VL - 55

SP - 915

EP - 925

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 4

ER -